Abivax SA header image

Abivax SA

ABVX

Equity

ISIN FR0012333284 / Valor 28479075

Euronext - Euronext Paris (2025-10-21)
EUR 79.60+1.02%

Abivax SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Abivax SA is a clinical-stage biotechnology company dedicated to the development of therapeutics aimed at modulating the body's natural regulatory mechanisms to manage chronic inflammatory diseases. The company's research and development efforts are centered on creating innovative treatments that can stabilize the immune response, potentially offering new solutions for conditions that currently have limited therapeutic options. By leveraging advanced biotechnological approaches, Abivax aims to address significant unmet medical needs in the field of immunology.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (17.10.2025):

Abivax SA has announced its financial results for the first half of 2025.

First Half 2025 Financial Results

Abivax SA presented its financial performance for the first half of 2025, as detailed in the company's report.

Summarized from source with an LLMView Source

Key figures

735%1Y
949%3Y
317%5Y

Performance

192%1Y
118%3Y
101%5Y

Volatility

Market cap

5865 M

Market cap (USD)

Daily traded volume (Shares)

34,786

Daily traded volume (Shares)

1 day high/low

6.99 / 6.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Genmab A/S
Genmab A/S Genmab A/S Valor: 1129757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.45%DKK 1,918.00
BELIMO Holding Ltd
BELIMO Holding Ltd BELIMO Holding Ltd Valor: 110109816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%CHF 806.50
ALSO Holding AG
ALSO Holding AG ALSO Holding AG Valor: 2459027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%CHF 233.50
Lem Holding SA
Lem Holding SA Lem Holding SA Valor: 2242762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%CHF 488.00
Landis+Gyr Group Ltd
Landis+Gyr Group Ltd Landis+Gyr Group Ltd Valor: 37115349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.79%CHF 62.40
Sensirion Holding Ltd.
Sensirion Holding Ltd. Sensirion Holding Ltd. Valor: 40670512
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.67%CHF 60.90
Burkhalter Holding Ltd
Burkhalter Holding Ltd Burkhalter Holding Ltd Valor: 21225580
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.71%CHF 140.80
Meier Tobler Group Ltd.
Meier Tobler Group Ltd. Meier Tobler Group Ltd. Valor: 20806262
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.92%CHF 38.45
Melexis NV
Melexis NV Melexis NV Valor: 723330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.97%EUR 64.85
Elma Electronic Ltd
Elma Electronic Ltd Elma Electronic Ltd Valor: 531916
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%CHF 1,250.00